DXR vs LH · P/E 6.5, rev $1.4M vs P/E 23, rev $13.95B
Daxor Corporation (DXR) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Daxor Corporation (DXR) is a medical instruments & supplies company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported DXR revenue for 2011-12-31 was $1.4M. Net income was -$7.2M. Revenue was down 8.4% from 2010-12-31 to 2011-12-31. DXR currently screens at market cap $61.9M and trailing P/E 6.5.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
DXR currently screens at market cap $61.9M and trailing P/E 6.5. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the DXR and LH stock pages for the full models.
Not investment advice.